Prognostic Factors and Long-Term Outcome of Pancreatic Neuroendocrine Neoplasms: Ki-67 Index Shows a Greater Impact on Survival than Disease Stage. The Large Experience of the Spanish National Tumor Registry (RGETNE)

Karger Terms and Conditions

General

Please address all your queries or problem reports to the Pay-per-View Customer Service at ppv@karger.com referring to PPV or PPV account.

1. All payments are by credit card only. The transaction is
secure: standard-procedure SSL or SET are used and all data are
encrypted. No separate invoice is issued/sent, only a
confirmation/receipt message with key details of the transaction. The
payment process will be operated by our partner SaferPay. Your credit
card data is not stored, copied or downloaded to Karger servers nor is
it passed on to third parties. None of this data will be used for
mailings or other promotional activities. Please see also the Karger Privacy Policy.

2. Please note that for security reasons, SaferPay may
refuse to accept more than 3 transactions per card per 24 hours, which
includes deductions from your Karger Pay-per-View account.

3. Purchases of online products (articles, book chapters in
electronic format) cannot be cancelled once the transaction is approved
and the confirmation sent. Such online items cannot be returned for
credit either.
Please note that these access rights cannot be transferred to another article/chapter or book online.

4. Ensure that you type in your e-mail address correctly (it
is also your User ID) and that your mailbox is ready to receive the
automatically generated confirmation and information messages from ppv@karger.com, e.g. one that includes your User ID and the password you created for reaccess.

5. Pay-per-view online access is for personal,
non-commercial use only. Items may be downloaded to one personal
computer and/or printed out for your convenience. Any distribution of
online items or the User ID/password to access them online is a
violation of the copyright.
Please see also the Karger Site Licenses for related information. Librarians, research assistants etc. who use this service on behalf of others are entitled to pass on the item to their client.

Direct Payment

6. The regular fee for pay-per-view online access to a single item
ranges from USD 28.00 to USD 38.00 depending on the length of
the article/chapter and permits 48-hours online access to the selected
item.
The fee for pay-per-view online book access (serial and
non-serial books, special/themed/supplement journal issues or Karger
ActiveBooks) equals the USD price for the same publication in print and
permits online access during 24 months to all articles/chapters of the
selected title. Access to entire titles is via direct payment only: it
is not possible to use your Karger pay-per-view account for pay-per-view
online book access.

Karger Pay-per-View Account / Payments from the Account

7. This option applies only to single journal and book
articles/chapter. Online access to entire books,
special/themed/supplement journal issues or Karger ActiveBooks is not
covered.

8. Your are entitled to purchasing online items at a special
reduced rate as long as your account is active and the balance shown is
more than or equals the reduced price of the item.

9. To open the account a deposit payment of at least USD 150 is required.

10. You can refill your account (with payments of at least USD 150) any time.

11. There are no refunds.
Deposits have to be used within two years of payments (down payment or last refill). Dormant accounts will be terminated irrespective of balance after a final reminder has been sent to the e-mail on file for the account.

Please address all your queries or problem reports to the Pay-per-View Customer Service at ppv@karger.com referring to PPV or PPV account.

Karger Terms and Conditions

General

Please address all your queries or problem reports to the Pay-per-View Customer Service at ppv@karger.com referring to PPV or PPV account.

1. All payments are by credit card only. The transaction is
secure: standard-procedure SSL or SET are used and all data are
encrypted. No separate invoice is issued/sent, only a
confirmation/receipt message with key details of the transaction. The
payment process will be operated by our partner SaferPay. Your credit
card data is not stored, copied or downloaded to Karger servers nor is
it passed on to third parties. None of this data will be used for
mailings or other promotional activities. Please see also the Karger Privacy Policy.

2. Please note that for security reasons, SaferPay may
refuse to accept more than 3 transactions per card per 24 hours, which
includes deductions from your Karger Pay-per-View account.

3. Purchases of online products (articles, book chapters in
electronic format) cannot be cancelled once the transaction is approved
and the confirmation sent. Such online items cannot be returned for
credit either.
Please note that these access rights cannot be transferred to another article/chapter or book online.

4. Ensure that you type in your e-mail address correctly (it
is also your User ID) and that your mailbox is ready to receive the
automatically generated confirmation and information messages from ppv@karger.com, e.g. one that includes your User ID and the password you created for reaccess.

5. Pay-per-view online access is for personal,
non-commercial use only. Items may be downloaded to one personal
computer and/or printed out for your convenience. Any distribution of
online items or the User ID/password to access them online is a
violation of the copyright.
Please see also the Karger Site Licenses for related information. Librarians, research assistants etc. who use this service on behalf of others are entitled to pass on the item to their client.

Direct Payment

6. The regular fee for pay-per-view online access to a single item
ranges from USD 28.00 to USD 38.00 depending on the length of
the article/chapter and permits 48-hours online access to the selected
item.
The fee for pay-per-view online book access (serial and
non-serial books, special/themed/supplement journal issues or Karger
ActiveBooks) equals the USD price for the same publication in print and
permits online access during 24 months to all articles/chapters of the
selected title. Access to entire titles is via direct payment only: it
is not possible to use your Karger pay-per-view account for pay-per-view
online book access.

Karger Pay-per-View Account / Payments from the Account

7. This option applies only to single journal and book
articles/chapter. Online access to entire books,
special/themed/supplement journal issues or Karger ActiveBooks is not
covered.

8. Your are entitled to purchasing online items at a special
reduced rate as long as your account is active and the balance shown is
more than or equals the reduced price of the item.

9. To open the account a deposit payment of at least USD 150 is required.

10. You can refill your account (with payments of at least USD 150) any time.

11. There are no refunds.
Deposits have to be used within two years of payments (down payment or last refill). Dormant accounts will be terminated irrespective of balance after a final reminder has been sent to the e-mail on file for the account.

Please address all your queries or problem reports to the Pay-per-View Customer Service at ppv@karger.com referring to PPV or PPV account.

Abstract

Introduction: Pancreatic neuroendocrine neoplasms (PNENs) are uncommon neoplasms with a wide spectrum of clinical behavior. The objective of this study was to assess in a large cohort of patients the relative impact of prognostic factors on survival. Methods: From June 2001 through October 2010, 1,271 patients were prospectively registered online (www.getne.org) at the Spanish National Cancer Registry for Gastroenteropancreatic Neuroendocrine Tumors (RGETNE) by participating centers. Clinical and histopathological features were assessed as potential prognostic factors by uni- and multivariate analyses. Results: Of 483 PNENs, 171 (35%) were functional (F) and 312 (65%) non-functional (NF). NF-PNENs were associated with a higher incidence of histological features denoting more aggressive disease, such as poor tumor differentiation, Ki-67 >20%, or vascular invasion (NF- vs. F-PNENs, respectively, p < 0.05). Nevertheless, functionality was not a significant predictor of survival (p = 0.19). Stage at diagnosis, Ki-67 index, tumor differentiation and surgical resection of the primary tumor were all significant prognostic factors in univariate analysis. However, Ki-67 (>20 vs. ≤2%) (hazard ratio (HR) 2.21, p = 0.01) and surgical resection (yes vs. no) (HR 0.92, p = 0.001) were the only independent predictors of survival in multivariate analysis. Among patients who underwent surgery, high Ki-67 index (HR 10.37, p = 0.02) and poor differentiation (HR 8.16, p = 0.03) were the only independent predictors of clinical outcome. Conclusion: Ki-67 index and tumor differentiation are key prognostic factors influencing survival of patients with PNENs and, in contrast to what it is observed for other solid malignancies, they seem to have a greater impact on survival than the extent of disease. This should be borne in mind by physicians in order to appropriately tailor therapeutic strategies and surveillance of these patients.

Article Information

Received: February 25, 2013
Accepted after revision: August 21, 2013
Published online: September 19, 2013
Number of Print Pages : 13
Number of Figures : 2, Number of Tables : 6, Number of References : 44Additional supplementary material is available online - Number of Parts : 2

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.